In Vitro Modeling of Age-Associated Lipid Mediator's Impact on Vascular Biology Following Platelet Concentrate Transfusion. [PDF]
Prier A +10 more
europepmc +1 more source
Uncovering a Glaucoma-Linked Lysophosphatidic Acid-MAPK/AP-1 Fibrosis Axis in Human Trabecular Meshwork Cells and Its Modulation by <i>Diospyros kaki</i> Leaf Extract. [PDF]
Jeon Y +10 more
europepmc +1 more source
Unraveling the Role of Autotaxin and Lysophosphatidic Acid in Alzheimer's Disease: From Molecular Mechanisms to Therapeutic Potential. [PDF]
García-de Soto J +14 more
europepmc +1 more source
Can a novel lysophosphatidic acid receptor 1 antagonist ACT in time to halt pulmonary fibrosis and improve breathing? [PDF]
Andresen BT.
europepmc +1 more source
Pharmacological Blockade of LPAR1 Does Not Provide Neuroprotection in a Rat Model of Ocular Hypertensive Glaucoma. [PDF]
Kocherlakota S +6 more
europepmc +1 more source
Lysophosphatidic acid receptor 1 (LPAR1; EDG2; LPA1) [PDF]
openaire +1 more source
Impact of tumor necrosis factor-alpha and lysophosphatidic acid on the behavior of ovarian cancer cells in a three-dimensional collagen hydrogel. [PDF]
Tino AB +3 more
europepmc +1 more source
Lysophosphatidic Acid Regulates Trafficking of β2-Adrenergic Receptors [PDF]
Elena Shumay +3 more
openaire +1 more source
Liraglutide attenuates aluminum chloride-induced Alzheimer's disease in rats by modulating the oxLDL/LPA/LPAR1 pathway. [PDF]
Abo El-Magd NF, Ramadan NM, Eraky SM.
europepmc +1 more source
Lysophosphatidic acid receptor 1 (LPAR1; EDG2; LPA1) [PDF]
openaire +1 more source

